TrialAmerican journal of clinical oncology2026

Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial.

Robin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.